Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Total Liabilities (2020 - 2026)

MDxHealth has reported Total Liabilities over the past 7 years, most recently at $181.1 million for Q1 2026.

  • For Q1 2026, Total Liabilities changed N/A year-over-year to $181.1 million; the TTM value through Mar 2026 reached $181.1 million, changed N/A, while the annual FY2025 figure was $160.0 million, 12.32% up from the prior year.
  • Total Liabilities was $181.1 million for Q1 2026 at MDxHealth, up from $160.0 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $181.1 million in Q1 2026 and bottomed at $109.8 million in Q4 2022.
  • The 5-year median for Total Liabilities is $142.5 million (2024), against an average of $143.1 million.
  • Year-over-year, Total Liabilities surged 289.81% in 2022 and then increased 11.02% in 2023.
  • Over 5 years, Total Liabilities stood at $109.8 million in 2022, then rose by 11.02% to $121.9 million in 2023, then rose by 16.87% to $142.5 million in 2024, then increased by 12.32% to $160.0 million in 2025, then increased by 13.13% to $181.1 million in 2026.
  • The last three reported values for Total Liabilities were $181.1 million (Q1 2026), $160.0 million (Q4 2025), and $142.5 million (Q4 2024) per Business Quant data.